Exercise as First-Line Treatment: Why Mental Health Guidelines Ignore Proven Depression and Anxiety Relief

Mental health crisis affecting 34% of Spanish population and 330 million globally, with young adults and postpartum women particularly underserved by current treatment approaches.
The question is no longer whether exercise works. Who will prescribe it?
Researchers argue clinical guidelines must treat structured exercise as primary treatment, not supplement, despite decades of evidence.

A major British Journal of Sports Medicine analysis of 63 studies and 80,000 participants confirms exercise reduces depression with moderate-high effects and anxiety with moderate effects across all age groups. Aerobic exercise in group settings works best for depression, while low-intensity programs lasting 8 weeks benefit anxiety sufferers who may experience intense exercise as additional stress.

  • 34% of Spanish population reported mental health problems in 2023, up 30% from pre-pandemic
  • Analysis of 63 studies and 80,000 participants shows exercise reduces depression with moderate-high effect, anxiety with moderate effect
  • Group aerobic exercise most effective for depression; low-intensity 8-week programs best for anxiety
  • Young adults (18-30) and postpartum women (12-15% affected by postpartum depression) show exceptional treatment response

Comprehensive research shows exercise effectively treats depression and anxiety, yet clinical guidelines rarely prescribe it as first-line treatment despite evidence suggesting effects may exceed antidepressants.

There is a treatment for depression and anxiety that requires no prescription, carries no risk of dependence, and simultaneously improves both mental and physical health. It is called exercise.

The contradiction is stark enough to demand attention. Spain's National Health System reported in 2023 that 34 percent of the population struggled with some form of mental illness—a 30 percent increase from before the pandemic. Globally, the World Health Organization estimates that depression and anxiety affect more than 330 million people. Yet when you look at what Spain's Ministry of Health recommends in 2024, you find cognitive behavioral therapy and antidepressants. Physical exercise appears in the margins, treated as an afterthought, something difficult to implement in practice.

A landmark study published in the British Journal of Sports Medicine has made this omission harder to justify. Researchers conducted the most comprehensive analysis to date on how exercise affects depression and anxiety, reviewing 63 scientific papers that contained 81 meta-analyses, more than 1,000 individual studies, and data from nearly 80,000 participants across all age groups. The findings are unambiguous: physical activity reduces depression symptoms with a moderate-to-high effect and anxiety symptoms with a moderate effect across every population examined. A separate assessment published in World Psychiatry suggests these effects may actually exceed those of antidepressant medications and psychotherapy—though researchers emphasize that direct head-to-head comparisons do not yet exist.

The neurobiological mechanisms explain why. Exercise elevates serotonin and norepinephrine, the same neurotransmitters that antidepressants regulate. It also trains the body to produce a more measured cortisol response to stress, building resilience against the daily triggers of anxiety and depression. But the new research goes beyond simply saying exercise helps. It specifies which types work best and for whom—the difference between evidence and actual prescription.

For depression, aerobic activity—running, brisk walking, swimming, cycling—produced the strongest effects. Equally important was the format: group exercise with professional supervision proved significantly more effective than solitary effort. Moving with others activates mechanisms of social belonging and mutual support that carry their own antidepressant power. For anxiety, the picture inverts. Long, intense programs do not deliver the best results. Instead, short interventions lasting up to eight weeks at low intensity show the strongest benefit. People with anxiety often experience intense exercise as additional physiological activation that mirrors their disorder's symptoms. A daily walk, yoga, or moderate regular activity offers the most evidence-backed approach.

Two populations emerged as deriving exceptional benefit—precisely those who receive the least clinical attention. Young adults between 18 and 30 bear the heaviest burden of the current mental health crisis, and this is when first episodes of depression and anxiety typically appear. They frequently encounter waiting lists and barriers to psychological care. Postpartum women represent the second group. Between 12 and 15 percent experience postpartum depression, a condition that remains underdiagnosed and stigmatized. Exercise offers a low-risk alternative during a period when medication raises additional concerns for many women.

Evidence has accumulated for years, yet exercise rarely appears in treatment plans as a first-line intervention. The reasons are multiple: clinicians lack training in exercise prescription, official protocols do not include it, and health systems structurally favor pharmaceutical approaches. There is also, frankly, cultural resistance. Something so accessible and inexpensive struggles to be taken seriously as a competitor to medication or years of therapy.

Exercise is not a cure for everything. Medication and psychotherapy remain irreplaceable in many cases. But the data are robust enough to demand a shift: clinical guidelines must incorporate structured exercise—supervised, in groups when possible, tailored to each person—as a first-line strategy. Not as a well-meaning supplement, but as treatment. The question is no longer whether exercise works. The question is who will prescribe it.

The effects of exercise may exceed those of antidepressant medications and psychotherapy
— World Psychiatry assessment cited in the research
Clinical guidelines must incorporate structured exercise as first-line strategy, not as a well-meaning supplement, but as treatment
— Raúl Fabero Garrido and Ibai López de Uralde Villanueva, Universidad Complutense de Madrid
La Conversación del Hearth Otra perspectiva de la historia
Inventor

The research seems overwhelming. Why hasn't this changed clinical practice already?

Model

Because changing how doctors think takes longer than publishing evidence. There's no financial incentive to prescribe exercise the way there is for pills. And honestly, many clinicians weren't trained to think of movement as medicine.

Inventor

But you're saying group exercise for depression works better than solo effort. That's a social finding, not just a biological one.

Model

Exactly. The antidepressant effect isn't just neurochemistry. It's belonging. That's harder to measure and harder to systematize than a dosage.

Inventor

And for anxiety, you're saying less is more. That seems counterintuitive.

Model

It is, until you understand that someone with anxiety already feels their body in overdrive. Intense exercise can feel like the panic attack itself. A gentle walk doesn't trigger that confusion.

Inventor

The postpartum women—why are they overlooked?

Model

Because postpartum depression is still treated as a personal weakness rather than a medical condition. And medication during nursing raises real questions. Exercise removes both barriers.

Inventor

So what would actually change if guidelines shifted?

Model

Young people and new mothers would get offered movement first, not after months on a waiting list. That's not a small thing.

Contáctanos FAQ